Leonard D. Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, CA, USA; Department of Pharmaceutical and Health Economics, School of Pharmacy, University of Southern California, Los Angeles, CA, USA.
Department of Medical Examiner-Coroner, County of Los Angeles, CA, USA.
Drug Alcohol Depend. 2021 Nov 1;228:109028. doi: 10.1016/j.drugalcdep.2021.109028. Epub 2021 Sep 2.
Opioid-related morbidity and mortality has increased during the COVID-19 pandemic, yet specific information about the communities most affected remains unknown. Our objective is to evaluate decedent-level associations with an opioid-related death following the implementation of stay-at-home orders in Los Angeles County.
This retrospective cohort study used data from the L.A. County Medical Examiner-Coroner to identify opioid-related deaths in 2019 and 2020. We used logistic regression to analyze the change in opioid-related deaths following a 30-day washout period after the start of stay-at-home orders. Independent variables included decedent age, gender, race and ethnicity, heroin or fentanyl present at the time of death, census tract-level education, and a scheduled drug prescription in the year before death.
Opioid-related deaths in L.A. County are most common in census tracts where a small percentage of the population has a Bachelor's degree. Following stay-at-home orders, Non-Hispanic Caucasian individuals had significantly more opioid-related deaths than Hispanic individuals (risk ratio (RR): 1.82 [95 % CI, 1.10-3.02]; P < 0.05) after adjusting for age, gender, and heroin or fentanyl use. Racial and ethnic differences in mortality were not explained by census tract-level education or recent scheduled drug prescriptions.
There has been an alarming rise in opioid-related deaths in L.A. County during 2020. The increase in opioid-related overdose deaths following the onset of COVID-19 and related policies occurred most often among Non-Hispanic Caucasian individuals. Further research on this trend's underlying cause is needed to inform policy recommendations during these simultaneous public health crises.
在 COVID-19 大流行期间,阿片类药物相关的发病率和死亡率有所增加,但有关受影响最严重的社区的具体信息仍不清楚。我们的目的是评估在洛杉矶县实施居家令后,与阿片类药物相关死亡相关的个体水平因素。
这是一项回顾性队列研究,使用洛杉矶县法医局的数据来确定 2019 年和 2020 年的阿片类药物相关死亡。我们使用逻辑回归分析了在居家令开始后 30 天的洗脱期后阿片类药物相关死亡的变化。自变量包括死者年龄、性别、种族和民族、死亡时是否存在海洛因或芬太尼、普查区教育程度以及死亡前一年的计划药物处方。
在洛杉矶县,阿片类药物相关死亡最常见于人口中拥有学士学位的比例较小的普查区。在实施居家令后,与西班牙裔个体相比,非西班牙裔白种人阿片类药物相关死亡的风险显著更高(风险比(RR):1.82[95%CI,1.10-3.02];P<0.05),校正年龄、性别和海洛因或芬太尼使用情况后。在调整了普查区教育程度和最近的计划药物处方后,种族和民族之间的死亡率差异仍存在。
在 2020 年,洛杉矶县的阿片类药物相关死亡人数急剧上升。在 COVID-19 及其相关政策开始后,阿片类药物相关过量死亡的增加最常发生在非西班牙裔白种人身上。需要进一步研究这种趋势的根本原因,以便在这两个同时发生的公共卫生危机期间为政策建议提供信息。